智能链接策略的最新进展,用于开发药物合物,用于有针对性的输送
Jie Zhang1, Zeyu Yang1, Yu Liu1
1School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.
Topics in current chemistry (Cham)
|March 13, 2025
概括
智能链接技术通过创建药物合物来增强向药物输送. 这些策略控制瘤内的药物释放,提高癌症治疗效率,减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 药物运输 药物运输 药物运输
- 在瘤学瘤学.
背景情况:
- 向药物递送系统旨在通过最大限度地减少化疗剂的非向毒性来改善癌症治疗.
- 使用刺激响应链接技术开发的药物合物对于控制在瘤部位的药物释放至关重要.
- 连接器技术在药物合物的设计,合成和体内性能方面是至关重要的,直接影响治疗结果.
研究的目的:
- 审查设计药物合物的智能链接策略,重点关注刺激响应药物释放.
- 讨论链接器分类,裂解机制,模块化链接器和药物合物的自我组装.
- 解决药物合联结策略的研究和临床应用中的挑战和考虑.
主要方法:
- 对药物合物的智能链接策略的当前文献的综述.
- 分析链接器分类,切割机制和模块化设计.
- 讨论自组装方法及其在药物合物中的应用.
- 检查研究和临床环境中链接策略的挑战和增强措施.
主要成果:
- 智能链接器能够控制细胞毒药物的释放,受瘤微环境和外部刺激的影响.
- 模块化连接器促进了高效的合合成,而自组装提供了新的设计可能性.
- 适当的链接策略可以实现细胞内药物释放后结合物内化,最大限度地杀死瘤细胞.
结论:
- 有效的链接策略对于优化药物合物设计和治疗疗效至关重要.
- 了解链接机制和刺激反应释放是推进向癌症治疗的关键.
- 对连接策略的持续研究,包括自我组装,对未来的药物合物开发具有重大前景.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
Phase II Conjugation Reactions: Overview
172
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
172
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
